标题
Targeting factor Xa and thrombin: impact on coagulation and beyond
作者
关键词
-
出版物
THROMBOSIS AND HAEMOSTASIS
Volume 111, Issue 04, Pages 625-633
出版商
Schattauer GmbH
发表日期
2013-12-12
DOI
10.1160/th13-09-0730
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation
- (2013) Torben Bjerregaard Larsen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
- (2013) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and Pharmacological Modifications of Thrombin Formation in Apolipoprotein E-deficient Mice Determine Atherosclerosis Severity and Atherothrombosis Onset in a Neutrophil-Dependent Manner
- (2013) Julian I. Borissoff et al. PLoS One
- Dabigatran Association With Higher Risk of Acute Coronary Events
- (2012) Ken Uchino ARCHIVES OF INTERNAL MEDICINE
- Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial
- (2012) Stefan H. Hohnloser et al. CIRCULATION
- Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregression
- (2012) Andre C Kalil et al. LANCET INFECTIOUS DISEASES
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc
- (2012) F. Bock et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor
- (2012) Mark Chan et al. THROMBOSIS AND HAEMOSTASIS
- Protease-Activated Receptor-2 Modulates Protease-Activated Receptor-1–Driven Neointimal Hyperplasia
- (2011) Leila M. Sevigny et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation
- (2011) H.-J. Wei et al. CARDIOVASCULAR RESEARCH
- “Triple Therapy” Rather Than “Triple Threat”
- (2011) Hong-Jin Zhao et al. CHEST
- Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial
- (2011) J. Oldgren et al. EUROPEAN HEART JOURNAL
- Blood coagulation factor Xa as an emerging drug target
- (2011) Keren Borensztajn et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Evaluation of Plaque Stability of Advanced Atherosclerotic Lesions in Apo E-Deficient Mice after Treatment with the Oral Factor Xa Inhibitor Rivaroxaban
- (2011) Qianxing Zhou et al. MEDIATORS OF INFLAMMATION
- The Hemostatic System as a Modulator of Atherosclerosis
- (2011) Julian Ilcheff Borissoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
- (2011) John H. Alexander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation
- (2011) S. Vetrano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system
- (2011) Nobutoshi Sugiyama et al. THROMBOSIS AND HAEMOSTASIS
- Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism
- (2010) Bengt I. Eriksson et al. Annual Review of Medicine
- Early Atherosclerosis Exhibits an Enhanced Procoagulant State
- (2010) Julian Ilcheff Borissoff et al. CIRCULATION
- Inflammation and coagulation
- (2010) Marcel Levi et al. CRITICAL CARE MEDICINE
- Newly Identified Events in the RE-LY Trial
- (2010) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Activated Protein C Protects Against Myocardial Ischemia/ Reperfusion Injury via Inhibition of Apoptosis and Inflammation
- (2009) Sarah T.B.G. Loubele et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Inhibition of Coagulation Activation and Inflammation by a Novel Factor Xa Inhibitor Synthesized from the Earthworm Eisenia andrei
- (2009) Seong Soo Joo et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Activated protein C action in inflammation
- (2009) Pranita P. Sarangi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Thrombin physiology and pathophysiology
- (2009) Louis G. Licari et al. JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reprint of Crosstalk between inflammation and thrombosis
- (2008) Charles T. Esmon MATURITAS
- Mechanisms of Thrombus Formation
- (2008) Bruce Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factor Xa: at the crossroads between coagulation and signaling in physiology and disease
- (2008) Keren Borensztajn et al. TRENDS IN MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now